Aspirin reduces the incidence of cancer in carriers of hereditary colorectal cancer

[NEWS 1 November 2011] Professor Annika Lindblom at the Department of Molecular Medicine and Surgery is co-author in a study that shows that regular use of aspirin substantially reduces the incidence of cancer in carriers of hereditary colorectal cancer.

• Press release from Newcastle University

Publication in the Lancet

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Lancet. 2011 Oct 27. [Epub ahead of print]

• Link to the abstract in PubMed
• Publication in the Lancet

Contact

Professor Annika Lindblom

Phone:

+46(0)8-517 752 48

E-mail:

• annika.lindblom@ki.se

Press Office

Phone:

+46(0)8-524 860 77

E-mail:

• pressinfo@ki.se